Hi Folks, Sam Kremer here,
Modular Medical (Nasdaq: MODD) today announced a strategic pilot collaboration with IMO Health, a healthcare technology company whose clinical terminology solutions are used across nearly all U.S. health systems.
News Link Here – snapshot below
Modular Medical & IMO Health Partner to Improve Patient Identification
The collaboration is designed to help clinicians identify diabetes patients who may benefit from Modular Medical's FDA-cleared Pivot™ tubeless insulin patch pump directly within electronic health records (EHRs).
The pilot combines IMO Health's clinical terminology platform with Modular Medical's patient-identification algorithms to help healthcare providers:
Identify insulin-dependent patients who may benefit from pump therapy.
Reduce time-consuming manual chart reviews.
Support more timely treatment decisions.
Prepare for Pivot™'s expected fourth-quarter commercial launch.
Management believes this technology could become an important part of the company's commercialization strategy by helping clinicians connect the right patients with the Pivot pump more efficiently.
The Bottom Line…
With FDA clearance secured, commercial rollout approaching, and new strategic partnerships supporting adoption, Modular Medical continues to execute on its commercialization strategy.
We'll continue monitoring MODD as additional catalysts emerge.
Sam Kremer
Editor, Profitable Trader Authority
© 2026 ProfitableTraderAuthority, All Rights Reserved. You are receiving this e mail as part of your subscription to ProfitableTraderAuthority.com. Nothing in this email should be considered personalized financial advice. PTA is neither a registered investment adviser nor a broker/dealer. Readers are advised that this electronic publication is issued solely for information purposes only and should not be construed as an offer to sell or the solicitation of an offer to buy any security. PTA is a financial publisher that does not offer any personal financial advice or advocate the purchase or sale of any security or investment for any specific individual. Pursuant to an agreement between PTA and STM LLC. PTA has been compensated fifteen thousand USD to publicly disseminate information about MODD via digital communications, for a period beginning on 7/14/26 and ending on 7/16/26. We own zero shares of MODD.